Admission Date: [**2169-9-23**]        Discharge Date:  Date of Birth:  [**2117-12-21**]        Sex:  M  Service:  NSU   HISTORY OF PRESENT ILLNESS:  This 51-year-old man with a newly diagnosed GBM status post resection on [**2169-9-8**] with residual right hemiparesis was discharged to rehabilitation but was noted to have increased word finding difficulties on [**2169-9-23**].
PAST MEDICAL HISTORY:  Significant for GBM diagnosed in [**9-/2169**], resected on [**2169-9-8**], with a plan to have radiation therapy done.
History of inflammatory bowel disease status post resection with ileostomy in [**2143**].
Decadron 2 mg p.o.
Hydrochlorothiazide 25 mg q day.
Lopressor 12.5 mg b.i.d.
Lipitor 10 mg q day.
Head CT showed air and blood products in the subdural space along the left convexity and surgical resection site and in the left cortex/basal ganglia with surrounding hypo-attenuation into the left caudate nucleus and internal capsule and thalamus.
HOSPITAL COURSE:  The patient was admitted to the Oncology service where he underwent a fever workup.
He also was started on Dilantin to rule out seizures given his change in mental status and he was given a dose of 10 mg intravenous and changed to 6 mg q six hours.
An Infectious Disease consultation was obtained and the patient was started on oxacillin 2 gm intravenously q four hours with a recommendation for six weeks.
For empiric coverage prior to starting the oxacillin, he was started on vancomycin and cefepime.
Those were discontinued on [**2169-9-26**] and as mentioned he was started on the oxacillin.
On [**2169-9-25**], the patient underwent a left-sided craniotomy for wound debridement and evacuation of subdural intracranial empyema.
His subcutaneous heparin was discontinued and a heparin panel was sent off.
Given that new finding, Interventional Radiology was contact[**Name (NI) **] and an inferior vena cava filter was placed.
They recommended avoiding all heparin and continuing argatroban only until it is clear that the platelets had normalized.
Further recommendations on [**2169-10-2**] from Hematology/Oncology was to discontinue the argatroban and to start a fondaparinux 7.5 mg subcutaneously q day and introduce Coumadin in the next 4-5 days continuing on the fondaparinux until his INR level was at 2.0, and he should continue on Coumadin therapy for four weeks.
Dr. [**Last Name (STitle) 739**] recommended transfusing one unit of packed red blood cells and starting on iron.
